Medicago’s COVID shot rejected by WHO over company’s tobacco links

The firm's Covifenz vaccine was jointly developed by Medicago, which is owned by Mitsubishi Chemical and Philip Morris, and GlaxoSmithKline.

参照元：Japan Times latest articles